WHITNEY MCCULLOUGH: Open Payments
NPI 1265071211 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 54 payments from 19 companies in 2025. Trend: 2023 $206 · 2024 $964 · 2025 $1,440
Food & beverage: $1,417Consulting: $23
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $182 |
| AstraZeneca Pharmaceuticals LP | 4 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $155 |
| Regeneron Healthcare Solutions, Inc. | 4 | $134 |
| Galderma Laboratories, L.P. | 2 | $130 |
| CSL Behring | 4 | $108 |
| Novartis Pharmaceuticals Corporation | 3 | $92 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $80 |
| GENZYME CORPORATION | 2 | $68 |
| Optinose US, Inc. | 2 | $50 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, NEMLUVIO, HYQVIA, NEFFY, Hizentra, Xhance.
Industry payments across FL — which companies pay providers there.
